Cyrano Therapeutics' Partnership

Cyrano Therapeutics raised a round of funding on October 31, 2017. Investors include New Summit BioPharma.

Cyrano Therapeutics has developed a proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. The Cyrano product repurposes an approved molecule for this n…

Articles about Cyrano Therapeutics' Partnership: